Companies: 10,795·Total market cap: $144.5T
Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V.

GNMLFOTCHealthcare● Active
$0.95
$-0.13(-12.04%)
Market Cap$928865018
P/E Ratio
52W High$1.17
52W Low$0.91

Genomma Lab Internacional, S.A.B. de C.V.(GNMLF)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · GNMLF · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$17.52B$18.61B$16.78B$16.91B$15.47B
Cost of Revenue$6.51B$6.68B$6.51B$6.69B$5.92B
Gross Profit$11.01B$11.93B$10.27B$10.22B$9.56B
Gross Margin %(computed)62.84%64.12%61.22%60.43%61.75%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$8.06B$118.38B$135.74B$134.82B
Total Operating Expenses$7.28B$8.03B$7.01B$6.90B$6.56B
Operating Income$3.73B$3.91B$3.27B$3.32B$2.99B
Operating Margin %(computed)21.26%20.99%19.49%19.64%19.35%
Interest Income$0.11B$0.11B$2.72B$0.12B$0.07B
Interest Expense$1.05B$0.89B$14.37B$0.53B$0.44B
Income Before Tax$2.43B$0.14B$29.79B$2.25B$27.75B
Income Tax Expense$0.83B$0.04B$11.00B$0.87B$0.91B
Net Income$1.61B$1.49B$1.11B$1.40B$1.31B
Net Margin %(computed)9.16%8.02%6.59%8.26%8.44%
Per Share & EBITDA
EPS (Basic)$1.65$1.53$1.15$1.41$1.30
Wtd Avg Shares0.97B0.98B0.96B0.99B1.01B
EBITDA$4.10B$4.14B$2.89B$3.00B$2.92B
EBITDA Margin %(computed)23.43%22.24%17.23%17.76%18.90%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · MXN · B

深入了解Genomma Lab Internacional, S.A.B. de C.V.

关于Genomma Lab Internacional, S.A.B. de C.V.(GNMLF)损益表

Genomma Lab Internacional, S.A.B. de C.V.(GNMLF)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,GNMLF实现营收$17.52B,毛利润$11.01B(毛利率62.84%),净利润$1.61B(净利率9.16%)。

常见问题

GNMLF · 4 问

Genomma Lab Internacional, S.A.B. de C.V.(GNMLF)2025财年营收为$17.52B,同比down5.8%。

GNMLF revenueGNMLF salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08